Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats
- PMID: 22660215
- DOI: 10.5507/bp.2012.028
Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats
Abstract
Aim: The present study was designed to investigate the activity of two glibenclamide derivatives on glucose concentration. An additional aim was to identify the biodistribution of glibenclamide derivatives in different organs in a diabetic animal model.
Methods: The effects of two glibenclamide derivatives on glucose concentration were evaluated in a diabetic animal model. In addition, glibenclamide derivatives were bound to Tc-99m using radioimmunoassay methods. To evaluate the pharmacokinetics of the glibenclamide derivatives over time (15, 30, 45 and 60 min) the Tc-99m-glibenclamide conjugates were used.
Results: The results showed that glibenclamide-pregnenolone had greater hypoglycemic activity than glibenclamide or glibenclamide-OH. The data also showed that the biodistribution of Tc-99m-glibenclamide-OH in all organs was less than that of the Tc-99m-glibenclamide-pregnenolone derivative.
Conclusions: The glibenclamide-pregnenolone derivative had greater hypoglycemic effects and its biodistribution was wider than glibenclamide-OH. The data suggest that the steroid nucleus may be important to the hypoglycemic activity of the glibenclamide-pregnenolone derivative and this could be related to the degree of lipophilicity induced by the steroid nucleus in the chemical structure of glibenclamide-pregnenolone.
Similar articles
-
New steroid derivative with hypoglycemic activity.Int J Clin Exp Med. 2014 Nov 15;7(11):3983-91. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25550906 Free PMC article.
-
Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats.J Ethnopharmacol. 2010 Apr 21;128(3):629-33. doi: 10.1016/j.jep.2010.01.008. Epub 2010 Jan 11. J Ethnopharmacol. 2010. PMID: 20064597
-
Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.Eur J Pharmacol. 2008 Jun 10;587(1-3):330-5. doi: 10.1016/j.ejphar.2008.03.043. Epub 2008 Apr 8. Eur J Pharmacol. 2008. PMID: 18462715
-
The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.Chem Biol Interact. 2008 May 9;173(1):68-75. doi: 10.1016/j.cbi.2007.11.012. Epub 2007 Dec 4. Chem Biol Interact. 2008. PMID: 18377884
-
Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats.Clin Exp Pharmacol Physiol. 2006 Sep;33(9):808-12. doi: 10.1111/j.1440-1681.2006.04444.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16922811
Cited by
-
New steroid derivative with hypoglycemic activity.Int J Clin Exp Med. 2014 Nov 15;7(11):3983-91. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25550906 Free PMC article.
-
Characterization and evaluation of mycosterol secreted from endophytic strain of Gymnema sylvestre for inhibition of α-glucosidase activity.Sci Rep. 2019 Nov 21;9(1):17302. doi: 10.1038/s41598-019-53227-w. Sci Rep. 2019. PMID: 31754154 Free PMC article.
-
Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.Eur J Drug Metab Pharmacokinet. 2015 Mar;40(1):1-12. doi: 10.1007/s13318-014-0186-9. Epub 2014 Mar 6. Eur J Drug Metab Pharmacokinet. 2015. PMID: 24596068 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical